the staff of the Ridgewood blog
Ridgewood NJ, surgeons at Duke University were the first to implant a new generation of Total Artificial Heart (TAH) after receiving FDA approval for human trials. The TAH has a variable heart rate that adjusts based on patient activity and can be used as a complete replacement for living donor hearts. Each device costs around $190,000, plus the costs of critical care staff and other medications. The device could solve long waitlists and high costs so that a heart will always be available for any patient in need.
